Epigenetic Pathways Offer Targets for Ovarian Cancer Treatment

Saved in:
Bibliographic Details
Published in:Clinical breast cancer 2018-06, Vol.18 (3), p.189-191
Main Authors: Gyparaki, Melina-Theoni, Papavassiliou, Athanasios G.
Format: Article
Language:English
Subjects:
Antineoplastic Agents - pharmacology
Antineoplastic Agents - therapeutic use
Carcinoma, Ovarian Epithelial - drug therapy
Carcinoma, Ovarian Epithelial - genetics
CpG Islands - genetics
DNA Methylation - drug effects
Drug Resistance, Neoplasm - drug effects
Drug Resistance, Neoplasm - genetics
Epigenesis, Genetic
Female
Gene Expression Regulation, Neoplastic - drug effects
Histone Code - drug effects
Histone Code - genetics
Humans
Neoplasms, Germ Cell and Embryonal - drug therapy
Neoplasms, Germ Cell and Embryonal - genetics
Ovarian Neoplasms - drug therapy
Ovarian Neoplasms - genetics
RNA, Untranslated - genetics
Signal Transduction - drug effects
Signal Transduction - genetics
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1526-8209
1938-0666
DOI:10.1016/j.clbc.2017.09.009